Advertisement

Topics

Companies Related to "TapImmune Amends Phase Clinical Trial Focus Larger Population" [Most Relevant Company Matches] RSS

10:12 EST 24th November 2017 | BioPortfolio

Here are the most relevant search results for "TapImmune Amends Phase Clinical Trial Focus Larger Population" found in our extensive corporate database of over 50,000 company records.

Showing "TapImmune Amends Phase Clinical Trial Focus Larger Population" Companies 1–25 of 6,900+

Monday 20th November 2017

Affinitas Health

Affinitas Health is an emergency and hospital medicine management services company that serves healthcare facilities across the United States. We take a genuine, people-centric approach to transform each practice we serve. Our founders are experienced clinicians who have worked together in a variety of clinical environments. We have united because we firml...


resTORbio, Inc.

resTORbio, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. resTORbio’s lead program is targeting the target of rapamycin complex 1 (TORC1) pathway to treat aging-related diseases and conditions with an initial focus on conditions caus...

Thursday 16th November 2017

Bridging Clinical Research & Clinical Health Care Collaborative


Wednesday 15th November 2017

Foley & Lardner LLP

With approximately 900 attorneys in 20 offices, Foley & Lardner LLP provides award-winning business and legal insight to clients across the country and around the world. Our team-based approach, innovative technology, and focus on value and client service are continually recognized by our clients and the legal industry. Foley has been recognized in a surve...

Vibrent Health

Vibrent Health is powering the future of precision medicine. Through a software-as-a-service (SaaS) platform for individual and population health, Vibrent accelerates discoveries around the complex relationships of cause and effect in human health, advancing personalized health and precision medicine so people can lead healthier, longer lives. Vibrent part...

Tuesday 14th November 2017

Scipio bioscience

Scipio bioscience develops a new generation of single-cell analysis sample preparation, to answer the growing need of clinical & fundamental research labs. The patent-based technology is based on an innovative chemical approach conceived by Prof. Stuart Edelstein, a world-famous bio-physician, very present in the academic and entrepreneurial worlds. The fi...

Exicure, Inc.

Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Exicure’s 3-dimensional, spherical nucleic acid (SNA™) architecture seeks to unlock the potential of nucleic acid therapeutics in multiple organs. Exicure’s lead programs address diseases from ...

Monday 13th November 2017

Ancillare, LP

Ancillare is the only organization of its kind with a singular focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying ...

Emerson Ecologics, LLC

Emerson Ecologics, LLC is the leading provider of products and services to the professional integrative healthcare community, distributing over 20,000 products from hundreds of industry leading manufacturers. They serve Naturopathic Doctors, Chiropractic Doctors, Licensed Acupuncturists, Dieticians, Medical Doctors, Nurses, and more. As a result of their broad product offering, e-commerce capabili...

Immunomic Therapeutics, Inc. (ITI)

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company headquartered in Hershey, PA with lab facilities in Rockville, MD. ITI is developing next generation vaccines based on its patented LAMP™ Technology platform. LAMP-Vax™ vaccine technology has the potential to significantly increase the effectiveness of the...

Arcus Biosciences

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which in February 2015 was acquired by Bristol-Myers Squibb to access Flexus’s IDO inhibitor, which was in preclinical...

Wednesday 8th November 2017

DisperSol Technologies LLC

DisperSol is an innovator in the formulation development and manufacture of pharmaceutical drugs. DisperSol’s KinetiSol® technology has dramatically improved the effectiveness of drugs by superior enhancement of drug loading, solubility, permeability and bioavailability relative to other technologies. This has enabled the improvement of approved dr...

vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

iVeena Delivery Systems, Inc.

iVeena Delivery Systems, Inc. (iVeena) is a privately held biopharmaceutical company that develops innovative ophthalmology products. iVeena utilizes a proprietary intracapsular drug delivery platform to enhance a medication’s ocular bioavailability to anterior and posterior eye segments. The lead product delivers dexamethasone to treat post-cataract ...

Stephens & Associates

Stephens & Associates is a contract research organization (CRO) with state-of-the-art technology and full service capabilities to maximize clinical success in all phases of testing for companies developing and manufacturing skin care products including pharmaceuticals, cosmetics, medical devices and personal care. With superior in-house scientific expertis...

Tuesday 7th November 2017

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular ...

Progenity Inc.

Progenity is a biotechnology company with a market-leading presence in Women’s Health molecular testing and a pipeline of proprietary tests and therapeutic applications under development. Progenity has a portfolio of innovative technologies and tests for pre-eclampsia, genetic carrier testing, inheritable cancer genetics, liquid biopsy and noninvasive ...

Vizient Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals,...

Monday 6th November 2017

Partners in Primary Care

Partners in Primary Care (Partners) is a primary care medical group practice and is part of a larger group of over 60 primary care offices in Florida, South Carolina and Texas operating under the names CAC Florida Medical Centers, Continucare Medical Centers, MetCare and Partners in Primary Care. Partners has a strong emphasis on senior-focused primary car...

Shared Health

With Clinical Insight, clinicians can access a practice management tool that presents a broad view of the care delivered across their patient population. Clinical Insight allows practices to generate reports that determine opportunities to provide care for specific groups of patients and ultimately improve outcomes for all patients.

COMS Interactive

COMS Interactive is advancing Post-Acute Care through quality improvement. COMS is focused on providing the platform for standard, evidence-based clinical care content. Built with over 20 years of research, COMS has 58 disease-specific, evidence-based Care Guides and assessments that guide and empower nurses. COMS ensures everyone involved - from doctors a...

Alcresta Therapeutics, Inc.

Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel enzyme-based products designed to treat gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency, which results in malabsorption common in cysti...

Thursday 2nd November 2017

Rheonix Inc.

Through experienced leadership and creative vision, Rheonix has developed the Encompass Optimum™ workstation, a highly customizable technology with unmatched versatility and affordability for use in research laboratories. The workstation performs fully automated, complex molecular assays in an easy-to-use and economical format on the Rheonix CARD® ...

Trans-Hit Bio

Trans-Hit Bio is the worldwide biospecimen access CRO with a most extensive collection capability for biospecimens and clinical samples through an unrivalled worldwide partnered-network of state-of-the-art biorepositories. We facilitate direct interactions between Industry and Academic Biobanks allowing the scientific and medical expertise of academics to ...

Wednesday 1st November 2017

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maint...


More From BioPortfolio on "TapImmune Amends Phase Clinical Trial Focus Larger Population"

Quick Search
Advertisement
 

Corporate Database Quicklinks